The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy.

Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study. Neth Heart J (2007) 0.76

Coronary revascularization, when it needs to be done it needs to be done. Eur Heart J (2001) 0.75

Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65

Consumer participation in research and health care. BMJ (1997) 3.38

What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med (1991) 3.33

Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17

A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14

Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med (1997) 3.08

What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke (1996) 2.84

Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62

Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens (1995) 2.58

Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44

A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med (1998) 2.42

Prognosis of abdominal aortic aneurysms. A population-based study. N Engl J Med (1989) 2.35

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol (2000) 2.22

PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19

Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18

Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15

Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08

Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol (1993) 2.05

A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03

Positive predictive value of clinical suspicion of abdominal aortic aneurysm. Implications for efficient use of abdominal ultrasonography. Arch Intern Med (1990) 2.02

Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation (1991) 1.99

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98

Variations by specialty in physician ratings of the appropriateness and necessity of indications for procedures. Med Care (1996) 1.98

Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94

Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia (2012) 1.85

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76

ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75

Contribution of a measure of disease complexity (COMPLEX) to prediction of outcome and charges among hospitalized patients. Mayo Clin Proc (1992) 1.75

Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol (1995) 1.75

A data-driven approach to improving the care of in-center hemodialysis patients. Health Care Financ Rev (1995) 1.75

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75

A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care (1985) 1.68

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation (1993) 1.68

Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. Circulation (1998) 1.67

Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66

Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure; the OSCUR study. Oucome dello Scompenso Cardiaco in relazione all'Utilizzo delle Risore. Eur Heart J (2001) 1.66

The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62

Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology (1992) 1.60

Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59

Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J (2002) 1.57

Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51

Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49

Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol (1995) 1.48

The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol (1986) 1.48

Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data. Eur Heart J (2002) 1.48

The Rochester Coronary Heart Disease Project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc (1989) 1.48

Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol (2001) 1.47

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46

The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc (1993) 1.45

Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45

The risk of bias from omitted research. BMJ (2000) 1.43

Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43

Use of beta-blocking agents in secondary prevention after myocardial infarction: a case for evidence-based medicine? GISSI experience, 1984-1993. The Gruppo Italiano di Studio sulla Sopravvivenza nell'Infarto Miocardico (GISSI) Investigators. Eur Heart J (1997) 1.41

[The history of the SET-UP study (or how difficult is neutrality in clinical research)]. Ital Heart J Suppl (2000) 1.40

Tropisetron or ondansetron compared with placebo for prevention of postoperative nausea and vomiting. Eur J Anaesthesiol (1998) 1.40

Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. Catheter Cardiovasc Interv (2005) 1.39

[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type]. Ital Heart J Suppl (2000) 1.39

[Editorial comment on: Cost analysis for DRG and PRG of the treatment of acute myocardial infarction in hospitalized patients]. G Ital Cardiol (1997) 1.38

The Olmsted County Benchmark Project: primary study findings and potential implications for corporate America. Mayo Clin Proc (1992) 1.38

A common and clonable environment to support research using patient data. Proc Annu Symp Comput Appl Med Care (1991) 1.37

Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J (1999) 1.36

Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) (1986) 1.35

Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34

Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Can J Cardiol (1997) 1.33

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32

Benign positional vertigo: incidence and prognosis in a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (1991) 1.28

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27

Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids (2001) 1.27

The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med (1992) 1.25

Promoting consumers' demand for evidence-based medicine. Int J Technol Assess Health Care (1998) 1.24

Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Arch Intern Med (2001) 1.22

Effect of panel composition on physician ratings of appropriateness of abdominal aortic aneurysm surgery: elucidating differences between multispecialty panel results and specialty society recommendations. Health Policy (1997) 1.22

Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation (1996) 1.22

Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology (1991) 1.21

Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. Health Serv Res (2000) 1.19

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab (2012) 1.19

Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. Am Heart J (2001) 1.17

Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol (2001) 1.16

Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum (1988) 1.14

Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr (2003) 1.14

Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med (1989) 1.13

Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project. Ann Intern Med (1995) 1.12

Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol (1993) 1.11

Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Ann Oncol (2010) 1.09